Clinical Trial

Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"

Study acronym: AHSPDREP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2025 (before its estimated March 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Evaluation of AHSP concentration in total blood as a biomarker in adult and pediatric sickle cell patients
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-11; most recent amendment 2025-03-28.
Status change: Not Yet Recruiting → Recruiting 2025-03-28
Trial Details
NCT Number NCT06735625
Lead Sponsor Centre Hospitalier de Saint-Denis
Collaborators: Inserm U955
Conditions in Relation to Sickle Cell Disease
Enrollment 100 participants
Start Date 2025-03-06
Primary Completion 2026-03-20 (estimated)
Study Completion 2027-01-20 (estimated)
Updated on ClinicalTrials.gov 2025-04-02